Summary of the recommendations on sexual dysfunctions in men
Montorsi, Francesco; Adaikan, Ganesan; Becher, Edgardo; Giuliano, Francois; Khoury, Saad; Lue, Tom F; Sharlip, Ira; Althof, Stanley E; Andersson, Karl-Eric; Brock, Gerald; Broderick, Gregory; Burnett, Arthur; Buvat, Jacques; Dean, John; Donatucci, Craig; Eardley, Ian; Fugl-Meyer, Kerstin S; Goldstein, Irwin; Hackett, Geoff; Hatzichristou, Dimitris; Hellstrom, Wayne; Incrocci, Luca; Jackson, Graham; Kadioglu, Ates; Levine, Laurence; Lewis, Ronald W; Maggi, Mario; McCabe, Marita; McMahon, Chris G; Montague, Drogo; Montorsi, Piero; Mulhall, John; Pfaus, Jim; Porst, Hartmut; Ralph, David; Rosen, Raymond; Rowland, David; Sadeghi-Nejad, Hossein; Shabsigh, Ridwan; Stief, Christian; Vardi, Yoram; Wallen, Kim; Wasserman, Marlene
INTRODUCTION/BACKGROUND:Sexual health is an integral part of overall health. Sexual dysfunction can have a major impact on quality of life and psychosocial and emotional well-being. AIM/OBJECTIVE:To provide evidence-based, expert-opinion consensus guidelines for clinical management of sexual dysfunction in men. METHODS:An international consultation collaborating with major urologic and sexual medicine societies convened in Paris, July 2009. More than 190 multidisciplinary experts from 33 countries were assembled into 25 consultation committees. Committee members established scope and objectives for each chapter. Following an exhaustive review of available data and publications, committees developed evidence-based guidelines in each area. Main Outcome Measures. New algorithms and guidelines for assessment and treatment of sexual dysfunctions were developed based on work of previous consultations and evidence from scientific literature published from 2003 to 2009. The Oxford system of evidence-based review was systematically applied. Expert opinion was based on systematic grading of medical literature, and cultural and ethical considerations. RESULTS:Algorithms, recommendations, and guidelines for sexual dysfunction in men are presented. These guidelines were developed in an evidence-based, patient-centered, multidisciplinary manner. It was felt that all sexual dysfunctions should be evaluated and managed following a uniform strategy, thus the International Consultation of Sexual Medicine (ICSM-5) developed a stepwise diagnostic and treatment algorithm for sexual dysfunction. The main goal of ICSM-5 is to unmask the underlying etiology and/or indicate appropriate treatment options according to men's and women's individual needs (patient-centered medicine) using the best available data from population-based research (evidence-based medicine). Specific evaluation, treatment guidelines, and algorithms were developed for every sexual dysfunction in men, including erectile dysfunction; disorders of libido, orgasm, and ejaculation; Peyronie's disease; and priapism. CONCLUSIONS:Sexual dysfunction in men represents a group of common medical conditions that need to be managed from a multidisciplinary perspective.
PMID: 21040491
ISSN: 1743-6109
CID: 5405552
History and physical examination
Chapter by: Onwubalili, Ndidiamaka; Sadeghi-Nejad, Hossein
in: Fertility Preservation in Male Cancer Patients by
[S.l.] : Cambridge University Press, 2010
pp. 39-50
ISBN: 9781107012127
CID: 5406882
Premature ejaculation: current medical treatment and new directions (CME)
Sadeghi-Nejad, Hossein; Watson, Richard
INTRODUCTION/BACKGROUND:Premature ejaculation (PE) is the most common form of male sexual dysfunction. Until very recently, scientific investigation of PE has been hampered by a lack of standardized definitions and objective, validated questionnaires. Small numbers of randomized controlled studies evaluating various treatment options have also added to the challenges facing the clinicians who manage PE. AIM/OBJECTIVE:This article provides a summary of some of the more relevant the peer-reviewed literature pertaining to the medical therapy of premature ejaculation. METHODS:A retrospective review of peer reviewed publications relevant to the field of premature ejaculation and related medical therapies. MAIN OUTCOME MEASURES/METHODS:Review of safety and efficacy of various medical therapies for premature ejaculation. RESULTS:Selective serotonin release inhibitors have been the most promising agents to date. The on-demand "PRN" use of these agents is more convenient, but its efficacy is less well established. Chronic use of this class of medications has been associated with minor, but bothersome side effects. More recently, concern over the risk of an increased suicide rate in young men upon initiation of SSRIs has dampened enthusiasm. Recent experience with the use of Tramadol raises the hope that this might prove to be an agent as effective as SSRIs with less worrisome risk of side-effects. New trials on novel formulations of topical solutions are currently underway in the United States. CONCLUSIONS:Interest in medical therapy for PE is rapidly increasing and reflected in a disproportionate number of publications in this field in the past few years. Clinical research in this field is hampered by the complexity, variability among different men and cultures, and subjectivity of PE. Reliable, appropriately controlled and assessed studies are generally lacking and carefully devised, methodically conducted research is much needed.
PMID: 18439148
ISSN: 1743-6109
CID: 5405502